Summary
In depressive states, theories concerning serotonin and norepinephrine have been dominating, but there are several lines of evidence indicating the involvement of the dopamine system as well, especially in suicidal depression. In this post-mortem study, the binding of the ligand [3H]WIN 35,428 to dopamine uptake sites in the caudate nucleus was investigated in 13 depressed suicide victims and 19 controls. There were no differences in Bmax or Kd between the suicide group and controls. Subdividing the suicide group into subgroups regarding the presence of major depression, antidepressant medication and suicide method, respectively, did not yield any differences. Previous findings regarding reduced CSF HVA in suicidal depression and indications of striatal dopaminergic biochemical and receptor changes in depression seem, according to the present study, not to be reflected by alterations in density or affinity of dopamine uptake sites in depressed suicide victims.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allard P (1994) Questions about the dopaminergic nature of [3H]GBR-12935 binding in the human frontal cortex — Reply. J Neurochem 63: 1182–1183
Allard P (1995) Questions about the dopamine terminals in human frontal cortex — Reply. J Neurochem 64: 1902–1903
Allard P, Alafuzoff I, Carlsson A, Eriksson K, Ericson E, Gottfries CG, Marcusson JO (1990a) Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease. Eur Neurol 30: 181–185
Allard P, Eriksson K, Ross SB, Marcusson JO (1990b) Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs. Psychopharmacol 102: 291–294
Allard P, Rinne J, Marcusson JO (1994) Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer type. Brain Res 637: 262–266
Allard P, Marcusson JO, Ross SB (1996) [3H]WIN 35,428 binding in the human brain. Brain Res 706: 347–350
Allison K, Paetsch PR, Baker GB, Greenshaw AJ (1993) Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding. Eur J Pharmacol 249: 125–131
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn revised (DSM-III-R). American Psychiatric Association, Washington DC
Baxter LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM (1985) Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 42: 441–447
Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, King AC, Hazlett E, Langston K, Post RM (1986) Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord 10: 137–152
Clarke RL, Daum SJ, Gambino AJ, Aceto MD, Pearl J, Levitt M, Cumiskey WR, Bogado EF (1973) Compounds affecting the central nervous system. 4.3β-Phenyltropane-2-carboxylic esters and analogs. J Med Chem 16: 1260–1267
Cummings JL (1992) Depression and Parkinson's disease: a review. Am J Psychiatry 149: 443–454
D'haenen HA, Bossuyt A (1994) Dopamine D2 receptors in depression measured with single photon emission computed tomography. Biol Psychiatry 35: 128–132
Farde L, Halldin C, Muller L, Suhara T, Karlsson P, Hall H (1994) PET study of [11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 16: 93–103
Hirai M, Kitamura N, Hashimoto T, Nakai T, Mita T, Shirakawa O, Yamadori T, Amano T, Noguchi-Kuno SA, Tanaka C (1988) [3H]GBR-12935 binding sites in human striatal membranes: binding characteristics and changes in parkinsonians and schizophrenics. Jpn J Pharmacol 47: 237–243
Janowsky A, Vocci F, Berger P, Angel I, Zelnik N, Kleinman JE, Skolnick P, Paul SM (1987) [3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease. J Neurochem 49: 617–621
Kuniyoshi M, Arikawa K, Miura C, Inanaga K (1989) Parkinsonism manifesting depression as the first sign. Jpn J Psychiatr Neurol 43: 37–43
Maloteaux JM, Vanisberg MA, Laterre C, Javoy-Agid F, Agid Y, Laduron PM (1988) [3H]GBR-12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy. Eur J Pharmacol 156: 331–340
Narabayashi H (1985) Pharmacological treatment of Parkinson's disease-past and future. Jpn J Neuropsychopharmacol 7: 713–728
Paetsch PR, Greenshaw AJ (1992) Effects of chronic antidepressant treatment on dopam-ine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum. Cell Mol Neurobiol 12: 597–606
Pearce RKB, Seeman P, Jellinger K, Tourtellotte WW (1990) Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia. Eur Neurol 30 [Suppl 1]: 9–14
Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G, Pozzera A, Deecke L, Podreka I, Brücke T (1995) β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm [Gen Sect] 100: 247–256
Pitchot W, Hansenne M, Gonzalez Moreno A, Ansseau M (1992) Suicidal behavior and growth hormone response to apomorphine test. Biol Psychiatry 31: 1213–1219
Roy A, Ågren H, Pickar D, Linnoila M, Doran AR, Cutler NR, Paul SM (1986) Reduced cerebrospinal fluid concentrations of homovanillic acid and homovanillic acid to 5-hydroxy-indoleacetic acid ratio in depressed patients: relationship to suicidality and dexamethasone nonsuppression. Am J Psychiatry 143: 1539–1545
Roy A, De Jong J, Linnoila M (1989) Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5 — year follow up. Arch Gen Psychiatry 46: 609–612
Suhara T, Nakayama K, Inoue O, Fukuda H, Shimizu M, Mori A, Tateno Y (1992) Dl dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacol 106: 14–18
Träskman L, Åsberg M, Bertilsson L, Sjöstrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38: 631–636
Valchar M, Bonnet JJ, Costentin J (1989) Chronic modification of dopaminergic transmission and its effects on binding characteristics of dopamine transporter ligand [3H]GBR 12783 in the striatum. Activ Nerv Super 31: 273–274
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allard, P., Norlén, M. Unchanged density of caudate nucleus dopamine uptake sites in depressed suicide victims. J. Neural Transmission 104, 1353–1360 (1997). https://doi.org/10.1007/BF01294736
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01294736